Close Menu

NEW YORK (GenomeWeb) ­– Abbott reported Wednesday morning that first quarter sales in its Diagnostics business grew 2 percent year over year, buoying flat overall revenue growth for the company.

For the three months ended March 31, Abbott reported overall Q1 revenues of $4.89 billion, down a fraction of a percent from Q1 last year, but up 5 percent year over year excluding unfavorable foreign currency effects. The company beat the consensus Wall Street estimate of $4.78 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.